Company intelligence / Profile preview

Siris Capital Group

New York, New York, United Statessiris.com ↗

Ownership: Private
Employees: ~34
Development stage: Other

Overview

Siris Capital Group is a private equity firm specializing in control-oriented investments in technology and technology-enabled services companies. The firm focuses on middle-market businesses, typically with $10 million to $50 million of EBITDA and transaction values between $100 million and $500 million. While its portfolio includes some healthcare-related companies (such as medical equipment or health tech), the firm itself is not primarily focused on life sciences, biotech, pharma, or healthcare[1][2][4][5].

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on Siris Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siris Capital Group.

Explore the full profile